StockData
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. (RDHL) stock

RDHLNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 27, 2026Score 0/30
$0.35−0.01 (-2.91%)

Close on Nov 17, 2026Market cap $1.78MP/E –Yield –

RedHill Biopharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

RedHill Biopharma's total debt was $115.22M at Dec 31, 2022. For fiscal 2022 it was $115.22M, up 37.8% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$115.22M+37.8%
FY2021Dec 31, 2021$83.62M+2.7%
FY2020Dec 31, 2020$81.39M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$115.22M+41.6%
Q2 FY2022Jun 30, 2022$85.51M+8.0%
Q4 FY2021Dec 31, 2021$83.62M–
Q2 FY2021Jun 30, 2021$83.16M–
Q4 FY2020Dec 31, 2020$81.39M–
Q2 FY2020Jun 30, 2020$79.19M–

More RedHill Biopharma figures

See a number that looks wrong?